Microbio Co., Ltd. (TPEX:4128)
10.90
-0.95 (-8.02%)
Nov 20, 2026, 1:30 PM CST
Microbio Revenue
Microbio had revenue of 456.71M TWD in the quarter ending September 30, 2026, a decrease of -3.60%. This brings the company's total for the last twelve months to 1.95B, up 4.85% year-over-year. In the year 2025, Microbio had annual revenue of 1.89B with 9.94% growth. That makes Microbio the 26,771st largest company in the world by revenue and 1,244th in Taiwan.
Revenue (ttm)
1.95B
Revenue Growth
+4.85%
P/S Ratio
3.29
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.41B
Revenue by Segment
- Health and vitality food 1.78B 93.8%
- Research and development of new medicine 116.95M 6.2%
Fiscal year ended Dec 31, 2025 See the full Microbio breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.89B | 171.26M | 9.94% |
| Dec 31, 2024 | 1.72B | 131.46M | 8.26% |
| Dec 31, 2023 | 1.59B | -130.46M | -7.58% |
| Dec 31, 2022 | 1.72B | -60.19M | -3.38% |
| Dec 31, 2021 | 1.78B | 180.64M | 11.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Namchow Holdings | 23.48B |
| Wei Chuan Foods | 21.46B |
| Formosa Oilseed Processing | 11.81B |
| Taisun Enterprise | 9.01B |
| Tehmag Foods | 7.13B |
| Ve Wong | 5.32B |
| AGV Products | 5.08B |
| Daiken Biomedical | 2.34B |